Phase 4 Ovarian Cancer Trial, Not Yet Recruiting NCT06871787 Sponsor: Istanbul University Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 4 Ovarian Cancer Trial, Not Yet Recruiting

NCT06871787
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 years or older.
  • People who have been diagnosed with a gynaecologic cancer (such as ovarian, endometrial, cervical, or vulvar cancer) that requires surgery.
  • People whose planned surgery includes removal of part of the bowel and reconnection of the remaining bowel ends.
  • People who are able and willing to agree to take part by signing a consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a known allergy or bad reaction to a substance called indocyanine green (ICG), which is a dye used during surgery.
  • People who are pregnant or breastfeeding at the time of surgery.
  • People who have serious liver or kidney problems that would make it unsafe to use ICG.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Samet Topuz, Prof., Istanbul University

Phone: +905057146233

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
Istanbul University
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 September 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Rate of Anastomotic Complications within 30 Days After Surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov